Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Evotec SE buy CandyButcher

Start price
€23.19
28.12.19 / 50%
Target price
-
28.02.20
Performance (%)
-7.76%
End price
€21.39
28.02.20
Summary
This prediction ended on 28.02.20 with a price of €21.39. With a performance of -7.76%, the BUY prediction for Evotec SE by CandyButcher closed slightly in the red. CandyButcher has a follow-up prediction for Evotec SE where he still thinks Evotec SE is a Buy. CandyButcher has 50% into this prediction

Evotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.

Performance without dividends (%)
Name 1w 1m 1y 3y
Evotec SE 4.356% 4.356% -19.558% -52.147%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by CandyButcher for this prediction

In the thread Evotec AG diskutieren

Buy Evotec AG

In the thread Trading Evotec AG
Prediction Buy
Perf. (%) -7.76%
Target price
Change
Ends at 28.02.20

Buy beendet

Current prediction by CandyButcher for Evotec SE

buy
Evotec SE

Start price
Target price
Perf. (%)
€17.16
10.05.23
-
10.05.24
-16.93%
10:41